Expertise in
9
conditions
Expertise in
9
conditions
San Juan, PR 

Overview

Luis Clavell is a Pediatric Hematologist Oncology provider in San Juan, Puerto Rico. Dr. Clavell is highly rated in 9 conditions, according to our data. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 24 peer reviewed articles and participating in 48 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatric Hematology Oncology

Licenses

Pediatric Hematology-Oncology in PR

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
First Medical Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
MMM Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D

Locations

San Juan, PR 00912

Additional Areas of Focus

Dr. Clavell has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


48 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 45 Less Clinical Trials
Similar Doctors
Expertise in
0
conditions
Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatric Hematology Oncology
Bayamon, PR 
 (7.2 miles away)
Languages Spoken:
English

Rosa Diaz is a Pediatric Hematologist Oncology provider in Bayamon, Puerto Rico. Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Immune Thrombocytopenic Purpura (ITP), Anemia, and Thrombocytopenia.

Expertise in
0
conditions
Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatric Hematology Oncology
Clinica De La Escuela De Medicina, Reparto Metropolitano Shopping, Ave. Americo Miranda, 
Rio Piedras, PR 
 (4.1 miles away)
Languages Spoken:
English

Enid Rivera is a Pediatric Hematologist Oncology provider in Rio Piedras, Puerto Rico. Her top areas of expertise are Evans Syndrome, Blood Clots, and Immune Thrombocytopenic Purpura (ITP).

Expertise in
0
conditions
Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatric Hematology Oncology
252 San Jorge St, Suite 504, 
Santurce, PR 
 (0.1 miles away)
Languages Spoken:
English

Maria Echevarria is a Pediatric Hematologist Oncology provider in Santurce, Puerto Rico. Her top area of expertise is Immune Thrombocytopenic Purpura (ITP).

Frequently Asked Questions about Dr. Luis A. Clavell

How do I make an appointment with Dr. Luis A. Clavell?

You can book an appointment with Dr. Luis A. Clavell by calling their office at 787-728-1575. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Luis A. Clavell a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Luis A. Clavell is classified as an Distinguished expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Luis A. Clavell specialize in?

While Dr. Luis A. Clavell is a Pediatric Hematology Oncology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Leukemia, and Reticulohistiocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.

Does Dr. Luis A. Clavell participate in research or clinical trials?

Yes. Dr. Luis A. Clavell has published 24 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Luis A. Clavell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Luis A. Clavell accept my insurance?

Dr. Luis A. Clavell accepts most major insurance plans, including Blue Cross Blue Shield and First Medical Health Plan. We recommend calling the office directly at 787-728-1575 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Clavell's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile